Using quantitative immunofluorescence, we investigated stromal TILs and PD-L1 protein expression in pre-treatment﻿ and residual breast cancer tissue from a Yale Cancer Center patient cohort of 58 patients diagnosed with breast cancer from 2003 to 2009 and treated with neoadjuvant chemotherapy. The gene discussed is CD274; the disease is cancer.